Publication: Enantioselective synthesis of 4-amino-3,4-dihydrocoumarins and their non-cyclic hydroxyester precursors: Biological evaluation for the treatment of glioblastoma multiforme.
dc.contributor.author | Borrego, Lorenzo G | |
dc.contributor.author | Recio, Rocío | |
dc.contributor.author | Moreno, Nazaret | |
dc.contributor.author | Chelouan, Ahmed | |
dc.contributor.author | Álvarez, Eleuterio | |
dc.contributor.author | Sánchez-Coronilla, Antonio | |
dc.contributor.author | Caro, Carlos | |
dc.contributor.author | Pearson, John R | |
dc.contributor.author | García-Martín, Maria Luisa | |
dc.contributor.author | Khiar, Noureddine | |
dc.contributor.author | Fernández, Inmaculada | |
dc.date.accessioned | 2023-05-03T14:56:36Z | |
dc.date.available | 2023-05-03T14:56:36Z | |
dc.date.issued | 2022-09-01 | |
dc.description.abstract | The stereoselective addition of ethyl acetate enolate to the C═N bond of N-tert-butylsulfinylimines has been investigated in depth. A significant effect of the LHMDS amount and the N-sulfinylimine nature on the stereoselectivity of the process was observed. Conditions were found where sulfinylimines of differently substituted salicylaldehydes derivatives, ethyl acetate, and LHMDS afforded the corresponding addition products as a single diastereomer in good yields. The developed protocol was successfully applied to the first stereoselective synthesis of differently substituted 4-amino-3,4-dihydrocoumarin derivatives. Computational models confirmed the prominent role of the ortho aryl substituent in the stereoselectivity of the process. A significant and selective cytotoxic activity against Glioblastoma Multiforme (GBM) cancer line has been determined for the noncyclic hydroxy ester derivative. | |
dc.identifier.doi | 10.1016/j.ejmech.2022.114730 | |
dc.identifier.essn | 1768-3254 | |
dc.identifier.pmid | 36088758 | |
dc.identifier.unpaywallURL | https://doi.org/10.1016/j.ejmech.2022.114730 | |
dc.identifier.uri | http://hdl.handle.net/10668/22187 | |
dc.journal.title | European journal of medicinal chemistry | |
dc.journal.titleabbreviation | Eur J Med Chem | |
dc.language.iso | en | |
dc.organization | Centro Andaluz de Nanomedicina y Biotecnología-BIONAND | |
dc.organization | Instituto de Investigación Biomédica de Málaga-IBIMA | |
dc.page.number | 114730 | |
dc.pubmedtype | Journal Article | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject | Enantiopure 4-amino-3,4-dihydrocoumarins | |
dc.subject | Glioblastoma multiforme | |
dc.subject | N-sulfinylarylimines | |
dc.subject | β-hydroxyesters | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Glioblastoma | |
dc.subject.mesh | Stereoisomerism | |
dc.subject.mesh | Esters | |
dc.subject.mesh | Antineoplastic Agents | |
dc.title | Enantioselective synthesis of 4-amino-3,4-dihydrocoumarins and their non-cyclic hydroxyester precursors: Biological evaluation for the treatment of glioblastoma multiforme. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 243 | |
dspace.entity.type | Publication |